Last reviewed · How we verify

Basophil Activation Test

University Hospital, Rouen · FDA-approved active Biologic

The Basophil Activation Test (BAT) is a flow cytometry-based diagnostic assay that measures basophil degranulation in response to allergen exposure to identify IgE-mediated allergic sensitization.

The Basophil Activation Test (BAT) is a flow cytometry-based diagnostic assay that measures basophil degranulation in response to allergen exposure to identify IgE-mediated allergic sensitization. Used for In vitro diagnosis of IgE-mediated allergic diseases, Assessment of allergic sensitization to specific allergens, Monitoring of allergen immunotherapy response.

At a glance

Generic nameBasophil Activation Test
SponsorUniversity Hospital, Rouen
ModalityBiologic
Therapeutic areaImmunology/Allergy
PhaseFDA-approved

Mechanism of action

BAT detects upregulation of activation markers (CD63, CD203c) on basophil surfaces when patient serum basophils are exposed to specific allergens in vitro. This functional test identifies IgE-mediated allergic responses and can quantify the degree of basophil reactivity, serving as a diagnostic tool for allergy assessment and potentially for monitoring immunotherapy response.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: